Keywords
Heart disease risk factors
Climacteric
Essential hypertension
Cholesterol HDL
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the clinical and metabolic parameters of women after natural or surgical menopause. Methods: We carried out a cross-sectional study in which we analyzed 686 medical records of women after natural or surgical menopause treated at the Menopause Outpatient Clinic of the Department of Obstetrics and Gynecology of a Public Hospital in São Paulo between 2020 and 2022. Data collected from medical records were: age, age at menopause, type of menopause, body mass index (BMI), waist circumference, blood pressure, HDL, triglycerides, fasting blood glucose and medication use. An interview was carried out about the use of medications during the consultation, and it was noted when the patient confirmed the use of any of these medications. Results: Women showed no difference between ages and age at menopause differed between groups. The average BMI of participants in both groups showed that they were obese (grade I obesity) and presented an increase in the average value of abdominal circumference and a high risk for cardiovascular diseases. Conclusion: The type of menopause did not lead to changes in the clinical parameters of women after natural or surgical menopause.
References
ACUÑA K and CRUZ T. Avaliação do estado nutricional de adultos e idosos e situação nutricional da população brasileira. Arq Bras Endocrinol Metab, 2004; 48(3): 345-61.
BARROSO WKS, et al. Diretrizes Brasileiras de Hipertensão Arterial – 2020. Arquivos Brasileiros de Cardiologia. Disponible in: https ://doi.org/10.36660/abc.20201238.
BRAY GA. Pathophysiologyofobesity. Amer J clin Nutr,1992; 8: 50-6.
CAROLYN J, et al. Body Mass Index Following Natural Menopause and Hysterectomywith and without Bilateral Oophorectomy. Int J Obes (Lond), 2013; 37(6): 809–813.
CARRION-MACHILENE MJ. OvercomingWomen’sLifelong Hormonal Rollercoaster: A Turning Point for Cardiovascular Prevention. Arq Bras Cardiol, 2022; 118(5): 914-915.
ELKHOUDARY S, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation, 2020; 142(25).
ERDÉLYI A, et al. The Importance of Nutrition in Menopause and Perimenopause- A Review. Nutrients, 2023; 16(1): 27.
FALUDI AA, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017; 109(2 -1): 1-76.
FERREIRA-CAMPOS L, et al. HormoneTherapy and Hypertension in PostmenopauseWomen: Resultsfrom the Brazilian Longitudinal StudyofAdult Health (ELSA-Brasil). Arq Bras Cardiol, 2022; 118(5): 905-913.
GONÇALVES VBS and LIMA SMRR. Menopause and metabolic syndrome: anthropometric, lipid, and dietary profiles. Rev Assoc Med Bras (1992), 2024; 70(6): 20231571.
KEYS A, et al. Indices of relative weight and obesity. J Chron Dis, 1972; 25: 329-43.
KO SH and KIM HS. Review Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women. Nutrients, 2020; 12: 202.
LEAN MEJ, et al. Waistcircumference as a measure for indicatingneed for weight management. BMJ, 1995; 311: 158-61.
LEE SW, et al. Relationship between metabolic syndrome and follicle-stimulating hormone in postmenopausal women. Medicine (Baltimore), 2022; 101(18): 29216.
MARCHI R, et al. Prevalence Of Metabolic Syndrome in pre- and postmenopausal women. Arch Endocrinol Metab, 2017; 61/2.
MARLATT KL, et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring), 2022; 30(1): 14-27.
MICHIEL HF, et al. Risks of Stroke and Heart Disease Following Hysterectomy and Oophorectomy in Chinese Premenopausal Women. Stroke, 2022; 53: 3064–3071.
MUMUSOGLU S and YILDIZ BO. Metabolic Syndrome During Menopause. Curr Vasc Pharmacol, 2019; 17(6): 595-603.
NACIF M and VIEBIG RF. Avaliação da composição corporal. In: NACIF M and VIEBIG RF. Avaliação antropométrica no ciclo da vida: uma visão prática. São Paulo: Metha, 2011; 2: 1-20.
PRÉCOMA DB, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol, 2019; 113(4): 787-891.
QUETELET A. Antropométrie ou mesure desdifférentes facultes de I’ homme. Bruxelles, C. Muquardt, 1870; 319-30.
TOTH P and PHAN B. Dyslipidemia in women: etiology and management. Int J Womens Health, 2014; 185.
WHO. WORD HEALTH ORGANIZATION. Obesity- preventing a managing the global epidemic. Report. Genebra: WHO, (Reportof a WHO Consultation on Obesity),1998; 209-30.
WILLETT W. Nutritional epidemiology. Oxford: Oxford University Press, 1998; 2: 25-50.
ZHANG Z, et al. The Effects of Estrogens on Neural Circuits That Control Temperature. Endocrinology, 2021; 162(8): 87.